About company
“Scandens Pharmaceuticals İndustries Ltd” offers large cooperation opportunities with other pharmaceutical companies in the areas of producers of manufacturing based on technology transfer, licensed production, and contract production.
The plant is designed by one of the leading consulting companies engaged in the pharmaceutical field who has more than 400 pharmaceutical successfully operating plants into their credit in various countries across the globe.
Plant current designed production capacity in the first stage is 600 million tablets and 150 million capsules, which will provide the need for tablet and capsule medicine forms of many therapeutic groups, such as cardiology, antidiabetic, anti-tuberculosis, analgesic, anti-inflammatory and others. More than 100 generic formulations are being planned to produce.